PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hypotension D007022 41 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Hyperalgesia D006930 42 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Leukemia P388 D007941 43 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Precancerous Conditions D011230 48 associated lipids
Thrombosis D013927 49 associated lipids
Osteosarcoma D012516 50 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Yang G et al. Systemic PPARγ deletion impairs circadian rhythms of behavior and metabolism. 2012 PLoS ONE pmid:22899986
Wang P et al. The antagonistic actions of endogenous interleukin-1β and 15-deoxy-Δ12,14-prostaglandin J2 regulate the temporal synthesis of matrix metalloproteinase-9 in sheared chondrocytes. 2012 J. Biol. Chem. pmid:22829602
Nicholson JD et al. PGJ(2) provides prolonged CNS stroke protection by reducing white matter edema. 2012 PLoS ONE pmid:23284631
Xiao L et al. Lipopolysaccharide-induced expression of microsomal prostaglandin E synthase-1 mediates late-phase PGE2 production in bone marrow derived macrophages. 2012 PLoS ONE pmid:23226252
Sykes L et al. Chemoattractant receptor homologous to the T helper 2 cell (CRTH2) is not expressed in human amniocytes and myocytes. 2012 PLoS ONE pmid:23226366
Yamaura K et al. Repeated application of glucocorticoids exacerbate pruritus via inhibition of prostaglandin D2 production of mast cells in a murine model of allergic contact dermatitis. 2012 J Toxicol Sci pmid:23208428
Wang Y et al. Optimization of phenylacetic acid derivatives for CRTH2 and DP selective antagonism. 2012 Bioorg. Med. Chem. Lett. pmid:22119474
Alba G et al. Transcription of liver X receptor is down-regulated by 15-deoxy-Δ(12,14)-prostaglandin J(2) through oxidative stress in human neutrophils. 2012 PLoS ONE pmid:23115616
Hossain MS et al. Stable expression of lipocalin-type prostaglandin D synthase in cultured preadipocytes impairs adipogenesis program independently of endogenous prostanoids. 2012 Exp. Cell Res. pmid:22100987
Pettipher R et al. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils. 2012 J. Pharmacol. Exp. Ther. pmid:22106101
Paulitschke V et al. Proteome analysis identified the PPARγ ligand 15d-PGJ2 as a novel drug inhibiting melanoma progression and interfering with tumor-stroma interaction. 2012 PLoS ONE pmid:23049949
Bain G et al. Pharmacodynamics, pharmacokinetics, and safety of AM211: a novel and potent antagonist of the prostaglandin D2 receptor type 2. 2012 J Clin Pharmacol pmid:22110163
Syeda PK et al. A monoclonal antibody specific for Δ12-prostaglandin J2 and its utilization in the immunological assay in cell culture system of adipocytes. 2012 Hybridoma (Larchmt) pmid:23098304
Gates D et al. Apo J/clusterin expression and secretion: evidence for 15-deoxy-Δ(12,14)-PGJ(2)-dependent mechanism. 2012 Biochim. Biophys. Acta pmid:22138303
Weng Y et al. Prostaglandin metabolite induces inhibition of TRPA1 and channel-dependent nociception. 2012 Mol Pain pmid:23013719
Ravindra KC et al. Targeting of histone acetyltransferase p300 by cyclopentenone prostaglandin Δ(12)-PGJ(2) through covalent binding to Cys(1438). 2012 Chem. Res. Toxicol. pmid:22141352
Maurer M and Church MK Inflammatory skin responses induced by icatibant injection are mast cell mediated and attenuated by H(1)-antihistamines. 2012 Exp. Dermatol. pmid:22142018
Fujimori K et al. Prevention of paraquat-induced apoptosis in human neuronal SH-SY5Y cells by lipocalin-type prostaglandin D synthase. 2012 J. Neurochem. pmid:22043816
Bardelli C et al. Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARγ ligands. 2012 Br. J. Pharmacol. pmid:21745193
Chae HS and Chin YW Anti-allergic effect of lambertianic acid from Thuja orientalis in mouse bone marrow-derived mast cells. 2012 Immunopharmacol Immunotoxicol pmid:21854102
Miyawaki T et al. Combination of midazolam and a cyclooxygenase-2 inhibitor inhibits lipopolysaccharide-induced interleukin-6 production in human peripheral blood mononuclear cells. 2012 Immunopharmacol Immunotoxicol pmid:21854184
Kanakasabai S et al. PPARγ agonists promote oligodendrocyte differentiation of neural stem cells by modulating stemness and differentiation genes. 2012 PLoS ONE pmid:23185633
Kaneko K et al. Novel orexigenic pathway prostaglandin D2-NPY system--involvement in orally active orexigenic δ opioid peptide. 2012 Neuropeptides pmid:23141054
Sedej M et al. D-type prostanoid receptor enhances the signaling of chemoattractant receptor-homologous molecule expressed on T(H)2 cells. 2012 J. Allergy Clin. Immunol. pmid:21930295
Higuchi S et al. Involvement of Th2 cytokines in the mouse model of flutamide-induced acute liver injury. 2012 J Appl Toxicol pmid:21735453
Pasvanis S et al. High sodium butyrate levels induce MDR1 activation in colorectal cells: Impact of 15-deoxy-Δ(12,14)-prostaglandin J(2) on the resistance to saquinavir. 2012 Biochem. Biophys. Res. Commun. pmid:22293191
Li X et al. Natural vanadium-containing Jeju groundwater inhibits immunoglobulin E-mediated anaphylactic reaction and suppresses eicosanoid generation and degranulation in bone marrow derived-mast cells. 2012 Biol. Pharm. Bull. pmid:22293352
Springstead JR et al. Evidence for the importance of OxPAPC interaction with cysteines in regulating endothelial cell function. 2012 J. Lipid Res. pmid:22550136
Xue L et al. Leukotriene E4 activates human Th2 cells for exaggerated proinflammatory cytokine production in response to prostaglandin D2. 2012 J. Immunol. pmid:22174450
He S et al. Identification, organ expression and ligand-dependent expression levels of peroxisome proliferator activated receptors in grass carp (Ctenopharyngodon idella). 2012 Comp. Biochem. Physiol. C Toxicol. Pharmacol. pmid:22079418
Clemente-Napimoga JT et al. 15d-PGJ2-loaded in nanocapsules enhance the antinociceptive properties into rat temporomandibular hypernociception. 2012 Life Sci. pmid:22564409
Inceoglu AB et al. Inhibition of soluble epoxide hydrolase limits niacin-induced vasodilation in mice. 2012 J. Cardiovasc. Pharmacol. pmid:22526297
Higashi N et al. Aspirin-intolerant asthma (AIA) assessment using the urinary biomarkers, leukotriene E4 (LTE4) and prostaglandin D2 (PGD2) metabolites. 2012 Allergol Int pmid:22627848
Kristensen DM et al. Paracetamol (acetaminophen), aspirin (acetylsalicylic acid) and indomethacin are anti-androgenic in the rat foetal testis. 2012 Int. J. Androl. pmid:22612476
Hogrefe C et al. Single impact cartilage trauma and TNF-α: interactive effects do not increase early cell death and indicate the need for bi-/multidirectional therapeutic approaches. 2012 Int. J. Mol. Med. pmid:22922824
Lee E et al. 15-Deoxy-Δ12,14-prostaglandin J₂ modulates manganese-induced activation of the NF-κB, Nrf2, and PI3K pathways in astrocytes. 2012 Free Radic. Biol. Med. pmid:22245093
Lee S et al. Lipocalin-type prostaglandin D2 synthase protein regulates glial cell migration and morphology through myristoylated alanine-rich C-kinase substrate: prostaglandin D2-independent effects. 2012 J. Biol. Chem. pmid:22275363
Ledwidge MT et al. In vivo impact of prodrug isosorbide-5-nicotinate-2-aspirinate on lipids and prostaglandin D2: is this a new immediate-release therapeutic option for niacin? 2012 Atherosclerosis pmid:22326030
Baek K et al. Myeloid Elf-1-like factor stimulates adipogenic differentiation through the induction of peroxisome proliferator-activated receptor γ expression in bone marrow. 2012 J. Cell. Physiol. pmid:22307523
Martínez AE et al. 15-Deoxy-Δ(12,14)-prostaglandin J2 exerts pro- and anti-inflammatory effects in mesangial cells in a concentration-dependent manner. 2012 Inflamm Allergy Drug Targets pmid:22309084
Fujita M et al. Cytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma. 2012 Int J Med Sci pmid:22991494
Ito H et al. PGD2-CRTH2 pathway promotes tubulointerstitial fibrosis. 2012 J. Am. Soc. Nephrol. pmid:22997255
Wu CC et al. Involvement of the prostaglandin D2 signal pathway in retinoid-inducible gene 1 (RIG1)-mediated suppression of cell invasion in testis cancer cells. 2012 Biochim. Biophys. Acta pmid:22960220
Song HH et al. Anti-inflammatory and anti-allergic effect of Agaricus blazei extract in bone marrow-derived mast cells. 2012 Am. J. Chin. Med. pmid:22928836
Tachikawa M et al. A clearance system for prostaglandin D2, a sleep-promoting factor, in cerebrospinal fluid: role of the blood-cerebrospinal barrier transporters. 2012 J. Pharmacol. Exp. Ther. pmid:22931759
Fredman G et al. Self-limited versus delayed resolution of acute inflammation: temporal regulation of pro-resolving mediators and microRNA. 2012 Sci Rep pmid:22957142
Matzkin ME et al. Exploring the cyclooxygenase 2 (COX2)/15d-Δ(12,14)PGJ(2) system in hamster Sertoli cells: regulation by FSH/testosterone and relevance to glucose uptake. 2012 Gen. Comp. Endocrinol. pmid:22974512
Myeku N et al. cAMP stimulates the ubiquitin/proteasome pathway in rat spinal cord neurons. 2012 Neurosci. Lett. pmid:22982149
Mechiche H et al. Prostanoid receptors involved in regulation of the beating rate of neonatal rat cardiomyocytes. 2012 PLoS ONE pmid:22984630
Shim J et al. Change in prostaglandin expression levels and synthesizing activities in dry eye disease. 2012 Ophthalmology pmid:22858125
Farnesi-de-Assunção TS et al. PPAR-γ agonists, mainly 15d-PGJ(2), reduce eosinophil recruitment following allergen challenge. 2012 Cell. Immunol. pmid:22192475
Kuriyan AE et al. Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation in vitro: a potentially novel therapy for corneal scarring. 2012 Exp. Eye Res. pmid:22178289
Yang K et al. [Changes of prostaglandin D2,carboxypeptidase A3 and platelet activating factor in guinea pig in anaphylactic shock]. 2012 Fa Yi Xue Za Zhi pmid:22812216
Komoda T and Nishikawa M 6'-Hydroxyoxosorbicillinol, a new lipoxygenase inhibitor and PGD2/LTB4 release suppressor from Penicillium sp. 2012 Biosci. Biotechnol. Biochem. pmid:22785490
Joo M and Sadikot RT PGD synthase and PGD2 in immune resposne. 2012 Mediators Inflamm. pmid:22791937
Baudouin-Legros M et al. Long-term CFTR inhibition modulates 15d-prostaglandin J2 in human pulmonary cells. 2012 Int. J. Biochem. Cell Biol. pmid:22481026
Weng Z et al. Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans. 2012 PLoS ONE pmid:22470478
Takahashi G et al. The potential role of prostaglandin D2 in nasal congestion observed in a guinea pig model of allergic rhinitis. 2012 Int. Arch. Allergy Immunol. pmid:22472859
Abdo H et al. The omega-6 fatty acid derivative 15-deoxy-Δ¹²,¹⁴-prostaglandin J2 is involved in neuroprotection by enteric glial cells against oxidative stress. 2012 J. Physiol. (Lond.) pmid:22473776
Ji Y et al. Activation of rat intestinal mucosal mast cells by fat absorption. 2012 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:22461027
Kim SE et al. 15-deoxy-Δ¹²,¹⁴ -prostaglandin J₂ inhibits human immunodeficiency virus-1 tat-induced monocyte chemoattractant protein-1/CCL2 production by blocking the extracellular signal-regulated kinase-1/2 signaling pathway independently of peroxisome proliferator-activated receptor-γ and heme oxygenase-1 in rat hippocampal slices. 2012 J. Neurosci. Res. pmid:22487967
Garza LA et al. Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia. 2012 Sci Transl Med pmid:22440736
Cloutier A et al. The prostanoid 15-deoxy-Δ12,14-prostaglandin-j2 reduces lung inflammation and protects mice against lethal influenza infection. 2012 J. Infect. Dis. pmid:22219346
Sykes L et al. Changes in the Th1:Th2 cytokine bias in pregnancy and the effects of the anti-inflammatory cyclopentenone prostaglandin 15-deoxy-Δ(12,14)-prostaglandin J2. 2012 Mediators Inflamm. pmid:22690041
Raman P et al. 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor γ ligand, modulates nuclear factor of activated T cells. 2012 J. Pharmacol. Exp. Ther. pmid:22700433
Cao DS et al. Expression of transient receptor potential ankyrin 1 (TRPA1) and its role in insulin release from rat pancreatic beta cells. 2012 PLoS ONE pmid:22701540
Yue L et al. Prostaglandin D2 induces apoptosis of human osteoclasts by activating the CRTH2 receptor and the intrinsic apoptosis pathway. 2012 Bone pmid:22705147
Napimoga MH et al. Exogenous administration of 15d-PGJ2-loaded nanocapsules inhibits bone resorption in a mouse periodontitis model. 2012 J. Immunol. pmid:22706081
Cebola I and Peinado MA Epigenetic deregulation of the COX pathway in cancer. 2012 Prog. Lipid Res. pmid:22580191
Liu X et al. 15-Deoxy-Δ(12,14)-prostaglandin J(2) attenuates the biological activities of monocyte/macrophage cell lines. 2012 Eur. J. Cell Biol. pmid:22560326
Gross-Sondej I et al. [Measurement of bronchoconstrictive eicosanoids in chronic obstructive pulmonary disease]. 2012 Pneumonol Alergol Pol pmid:22370980
Han Z et al. 15-deoxy-Δ12,14 -prostaglandin J2 reduces recruitment of bone marrow-derived monocyte/macrophages in chronic liver injury in mice. 2012 Hepatology pmid:22371273
Syeda PK et al. Generation of monoclonal antibody for 15-deoxy-Δ¹²,¹⁴-prostaglandin J₂ and development of enzyme-linked immunosorbent assay for its quantification in culture medium of adipocytes. 2012 Appl. Biochem. Biotechnol. pmid:22391692
Quinteiro MS et al. The indirect antinociceptive mechanism of 15d-PGJ2 on rheumatoid arthritis-induced TMJ inflammatory pain in rats. 2012 Eur J Pain pmid:22354681
Prage EB et al. Observation of two modes of inhibition of human microsomal prostaglandin E synthase 1 by the cyclopentenone 15-deoxy-Δ(12,14)-prostaglandin J(2). 2012 Biochemistry pmid:22356188
Numazawa S et al. Possible involvement of transient receptor potential channels in electrophile-induced insulin secretion from RINm5F cells. 2012 Biol. Pharm. Bull. pmid:22382320
Lin YC et al. The glutathionylation of p65 modulates NF-κB activity in 15-deoxy-Δ¹²,¹⁴-prostaglandin J₂-treated endothelial cells. 2012 Free Radic. Biol. Med. pmid:22387200
Carsin A et al. [Physiopathology of aspirin intolerant asthma]. 2012 Rev Mal Respir pmid:22405107
Song WL et al. Niacin and biosynthesis of PGDâ‚‚by platelet COX-1 in mice and humans. 2012 J. Clin. Invest. pmid:22406532
Nagata N and Urade Y [Endogenous sleep-promoting substance]. 2012 Nippon Rinsho pmid:22844810
Philipose S et al. Laropiprant attenuates EP3 and TP prostanoid receptor-mediated thrombus formation. 2012 PLoS ONE pmid:22870195
Rahman MS et al. Cultured preadipocytes undergoing stable transfection with cyclooxygenase-1 in the antisense direction accelerate adipogenesis during the maturation phase of adipocytes. 2013 Appl. Biochem. Biotechnol. pmid:23817787
Aldrovandi M et al. Human platelets generate phospholipid-esterified prostaglandins via cyclooxygenase-1 that are inhibited by low dose aspirin supplementation. 2013 J. Lipid Res. pmid:23883581
Fujishima H et al. Chemotactic responses of peripheral blood eosinophils to prostaglandin D2 in atopic keratoconjunctivitis. 2013 Ann. Allergy Asthma Immunol. pmid:23886231
Lu Y et al. 15-Deoxy-Δ(12,14)-prostaglandin J(2) modulates lipopolysaccharide-induced chemokine expression by blocking nuclear factor-κB activation via peroxisome proliferator activated receptor-γ-independent mechanism in renal tubular epithelial cells. 2013 Nephron Exp. Nephrol. pmid:23887394
Takayama F et al. Possible involvement of aiPLA2 in the phosphatidylserine-containing liposomes induced production of PGE2 and PGD2 in microglia. 2013 J. Neuroimmunol. pmid:23850486
Nakagawa T et al. A prostaglandin D2 metabolite is elevated in the urine of Duchenne muscular dystrophy patients and increases further from 8 years old. 2013 Clin. Chim. Acta pmid:23603101
Sykes L et al. The CRTH2 agonist Pyl A prevents lipopolysaccharide-induced fetal death but induces preterm labour. 2013 Immunology pmid:23374103
Nelson AM et al. Prostaglandin D2 inhibits wound-induced hair follicle neogenesis through the receptor, Gpr44. 2013 J. Invest. Dermatol. pmid:23190891
Kaikkonen S et al. Prostaglandin 15d-PGJ(2) inhibits androgen receptor signaling in prostate cancer cells. 2013 Mol. Endocrinol. pmid:23192983
Schmidt JA et al. Biochemical and pharmacological characterization of AZD1981, an orally available selective DP2 antagonist in clinical development for asthma. 2013 Br. J. Pharmacol. pmid:23146091
Aukema HM et al. Dietary fish oil reduces glomerular injury and elevated renal hydroxyeicosatetraenoic acid levels in the JCR:LA-cp rat, a model of the metabolic syndrome. 2013 Br. J. Nutr. pmid:23151363
Frieri M et al. Mast cell activation syndrome: a review. 2013 Curr Allergy Asthma Rep pmid:23179866
Kaur R et al. A phenotypic screening approach in cord blood-derived mast cells to identify anti-inflammatory compounds. 2013 J Biomol Screen pmid:23983232
Liu H et al. Prostaglandin D2 toxicity in primary neurons is mediated through its bioactive cyclopentenone metabolites. 2013 Neurotoxicology pmid:23973622
Bogacka I et al. The involvement of peroxisome proliferator activated receptors (PPARs) in prostaglandin F2α production by porcine endometrium. 2013 Reprod Biol pmid:24287039
Mruwat R et al. Phospholipase A2 in experimental allergic bronchitis: a lesson from mouse and rat models. 2013 PLoS ONE pmid:24204651
Brose SA and Golovko MY Eicosanoid post-mortem induction in kidney tissue is prevented by microwave irradiation. 2013 Prostaglandins Leukot. Essent. Fatty Acids pmid:24113545
Sayers BC et al. Role of cyclooxygenase-2 in exacerbation of allergen-induced airway remodeling by multiwalled carbon nanotubes. 2013 Am. J. Respir. Cell Mol. Biol. pmid:23642096
Tan BS et al. 6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ). 2013 Cancer Lett. pmid:23612072